SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...
This transcript has been edited for clarity. Jay H. Shubrook, DO: Hi. I'm Jay Shubrook, a professor of primary care at Touro University California in the College of Osteopathic Medicine and a ...
So-called 'smart' insulin took a step nearer to becoming a reality with a new study from Denmark, the United Kingdom, and the Czech Republic. Researchers reported in Nature that animal tests with an ...
The U.S. Food and Drug Administration (FDA) has approved Merilog, a biosimilar to the widely used insulin product Novolog (insulin aspart), to enhance glycemic control in adults and children with ...
Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. The Danish drugmaker plans to ...
Invictus Therapeutics, a biotechnology company developing next-generation insulin analogs engineered for automated insulin delivery systems, today announced it has received an Industry Discovery and ...
India’s Cipla Limited (BSE: 500087) announced the launch of Afrezza (insulin human) Inhalation Powder in India.
AZoLifeSciences on MSN
Turning human fat into insulin-producing organoids that reverse diabetes
By preserving fat tissue architecture, researchers created organoids that restore insulin function, paving the way for ...
Interesting Engineering on MSN
Human fat creates organoids for bone marrow, neural tissue, and insulin secretion
The study shows that fat tissue, when processed and cultured in a specific way, can self-organize into structures resembling bone marrow, pancreatic islets, and even neural tissue. These organoids ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results